B · Normal
On November 4th, the innovative drug sector of the Hong Kong stock market continued its rise. WuXi AppTec rose by more than 12%, BeiGene rose by more than 10%, and Kangfang Biologics, Simcere Pharmaceuticals, etc. followed suit.
Comments